CRDACCardiovascular and Renal Drugs Advisory Committee
References in periodicals archive ?
M2 PHARMA-February 24, 2012-FDA's CRDAC advises approval of Northera for NOH(C)2012 M2 COMMUNICATIONS
Revised Class Labeling Based on Data Discussed at the May 2007 ODAC and September 2007 CRDAC Meetings
Roche and all other sponsors of ESAs in the United States have been informed of the upcoming CRDAC in the fall, and it is understood that recommendations from this meeting could impact the entire class labeling for all ESAs.